SEARCH

SEARCH BY CITATION

Literature Cited

  • Ambrose JA. 2006. Myocardial ischemia and infarction. J Am Coll Cardiol 47: D1317.
  • Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJ. 2005. Endothelial progenitor cell capture by stents coated with antibody against CD34: The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 45: 15741579.
  • Arden N, Nevitt MC. 2006. Osteoarthritis: Epidemiology. Best Pract Res Clin Rheumatol 20: 325.
  • Armitage JO. 1994. Bone marrow transplantation. N Engl J Med 330: 827838.
  • Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM. 2002. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106: 30093017.
  • Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 4248.
  • Bembi B, Parma A, Bottega M, Ceschel S, Zanatta M, Martini C, Ciana G. 1997. Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr 131: 622625.
  • Beyer Nardi N, da Silva Meirelles L. 2006. Mesenchymal stem cells: Isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174: 249282.
  • Bianco P, Gehron Robey P. 2000. Marrow stromal stem cells. J Clin Invest 105: 16631668.
  • Bianco P, Riminucci M, Gronthos S, Gehron Robey P. 2001. Bone marrow stromal stem cells: Nature, biology and potential applications. Stem Cells 19: 180192.
  • Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M. 2001. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189: 4957.
  • Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP. 2004. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94: 9295.
  • D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. 2004. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117: 29712981.
  • Deans RJ, Moseley AB. 2000. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 28: 875884.
  • Delcarpio JB, Claycomb WC. 1995. Cardiomyocyte transfer into the mammalian heart. Cell-to-cell interactions in vivo and in vitro. Ann N Y Acad Sci 752: 267285.
  • Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 38383843.
  • Ferrara JL, Reddy P. 2006. Pathophysiology of graft-versus-host disease. Semin Hematol 43: 310.
  • Ferrara JL, Yanik G. 2005. Acute graft versus host disease: Pathophysiology, risk factors, and prevention strategies. Clin Adv Hematol Oncol 3: 415419, 428.
  • Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279: 15281530.
  • Field RE, Buchanan JA, Copplemans MG, Aichroth PM. 1994. Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development. J Bone Joint Surg Br 76: 975981.
  • Forte A, Di Micco G, Galderisi U, Guarino FM, Cipollaro M, De Feo M, Gregorio R, Bianco MR, Vollono C, Esposito F, Berrino L, Angelini F, Renzulli A, Cotrufo M, Rossi F, Cascino A. 2001. Molecular analysis of arterial stenosis in rat carotids. J Cell Physiol 186: 307313.
  • Forte A, Cipollaro M, Cascino A, Galderisi U. 2005. Small interfering RNAs and antisense oligonucleotides for treatment of neurological diseases. Curr Drug Targets 6: 2129.
  • Fouillard L, Bensidhoum M, Bories D, Bonte H, Lopez M, Moseley AM, Smith A, Lesage S, Beaujean F, Thierry D, Gourmelon P, Najman A, Gorin NC. 2003. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 17: 474476.
  • Galderisi U, Cascino A, Giordano A. 1999. Antisense oligonucleotides as therapeutic agents. J Cell Physiol 181: 251257.
  • Ge Z, Hu Y, Heng BC, Yang Z, Ouyang H, Lee EH, Cao T. 2006. Osteoarthritis and therapy. Arthritis Rheum 55: 493500.
  • Giebel LB. 2005. Stem cells—A hard sell to investors. Nat Biotechnol 23: 798800.
  • Gieselmann V. 2003. Metachromatic leukodystrophy: Recent research developments. J Child Neurol 18: 591594.
  • Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. 1999. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5: 309313.
  • Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK. 2001. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97: 12271231.
  • Jin HK, Carter JE, Huntley GW, Schuchman EH. 2002. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J Clin Invest 109: 11831191.
  • Jori FP, Napolitano MA, Melone MA, Cipollaro M, Cascino A, Altucci L, Peluso G, Giordano A, Galderisi U. 2005. Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells. J Cell Biochem 94: 645655.
  • Katritsis DG, Sotiropoulou PA, Karvouni E, Karabinos I, Korovesis S, Perez SA, Voridis EM, Papamichail M. 2005. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 65: 321329.
  • Koc ON, Lazarus HM. 2001. Mesenchymal stem cells: Heading into the clinic. Bone Marrow Transplant 27: 235239.
  • Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. 2000. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18: 307316.
  • Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. 2002. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30: 215222.
  • Krivit W, Peters C, Shapiro EG. 1999. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 12: 167176.
  • Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. 1995. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use. Bone Marrow Transplant 16: 557564.
  • Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Jr., Moseley AB, Bacigalupo A. 2005. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11: 389398.
  • Le Blanc K, Pittenger M. 2005. Mesenchymal stem cells: Progress toward promise. Cytotherapy 7: 3645.
  • Lee ST, Jang JH, Cheong JW, Kim JS, Maemg HY, Hahn JS, Ko YW, Min YH. 2002. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol 118: 11281131.
  • Leor J, Patterson M, Quinones MJ, Kedes LH, Kloner RA. 1996. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation 94: II332336.
  • Marini JC, Gerber NL. 1997. Osteogenesis imperfecta. Rehabilitation and prospects for gene therapy. JAMA 277: 746750.
  • Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, Pastore I, Marasso R, Madon E. 2003. Stem cell therapy in amyotrophic lateral sclerosis: A methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 4: 158161.
  • Muller-Sieburg CE, Deryugina E. 1995. The stromal cells' guide to the stem cell universe. Stem Cells 13: 477486.
  • Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. 1996. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98: 25122523.
  • Onyia JE, Clapp DW, Long H, Hock JM. 1998. Osteoprogenitor cells as targets for ex vivo gene transfer. J Bone Miner Res 13: 2030.
  • Park C, Ma YD, Choi K. 2005. Evidence for the hemangioblast. Exp Hematol 33: 965970.
  • Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, Prockop DJ. 1995. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92: 48574861.
  • Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. 2003. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107: 22942302.
  • Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Silva GV, Mesquita CT, Belem L, Vaughn WK, Rangel FO, Assad JA, Carvalho AC, Branco RV, Rossi MI, Dohmann HJ, Willerson JT. 2004. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110: II213218.
  • Peters C, Shapiro EG, Krivit W. 1998. Hurler syndrome: Past, present, and future. J Pediatr 133: 79.
  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multineage potential of adult human mesenchimal stem cell. Science 284: 143147.
  • Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 7174.
  • Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. 2001. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98: 26152625.
  • Sammarco VJ, Chang L. 2002. Modern issues in bone graft substitutes and advances in bone tissue technology. Foot Ankle Clin 7: 1941.
  • Sethe S, Scutt A, Stolzing A. 2006. Aging of mesenchymal stem cells. Ageing Res Rev 5: 91116.
  • Silber S. 2006. Capturing circulating endothelial progenitor cells: A new concept tested in the HEALING studies. Minerva Cardioangiol 54: 13.
  • Soonpaa MH, Koh GY, Klug MG, Field LJ. 1994. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264: 98101.
  • Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G. 2003. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 4546.
  • Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, Kogler G, Wernet P. 2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 19131918.
  • Sweigart MA, Athanasiou KA. 2001. Toward tissue engineering of the knee meniscus. Tissue Eng 7: 111129.
  • Tabbara IA, Zimmerman K, Morgan C, Nahleh Z. 2002. Allogeneic hematopoietic stem cell transplantation: Complications and results. Arch Intern Med 162: 15581566.
  • Tanaka K, Sata M, Hirata Y, Nagai R. 2003. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 93: 783790.
  • Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. 1998. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 4: 929933.
  • Tomita S, Li RK, Weisel RD, Mickle DA, Kim EJ, Sakai T, Jia ZQ. 1999. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100: II247256.
  • Urbich C, Dimmeler S. 2004. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 95: 343353.
  • Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM. 2002. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 30173024.
  • Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. 2004. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364: 141148.
  • Xu Y, Arai H, Zhuge X, Sano H, Murayama T, Yoshimoto M, Heike T, Nakahata T, Nishikawa S, Kita T, Yokode M. 2004. Role of bone marrow-derived progenitor cells in cuff-induced vascular injury in mice. Arterioscler Thromb Vasc Biol 24: 477482.
  • Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836841.
  • Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. 2002. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 174: 1120.